In this section
Showing 77 results
These novel compounds could be used in the treatment of antibiotic resistant bacterial infections and demonstrate that inhibitors of NorA efflux can prevent the emergence of further resistant strains.
LhARA uses laser-driven proton beams for precise, high-dose cancer therapy, enabling compact, flexible treatment systems and radiobiological research.
Mouse model mimics AMD pathology, enabling preclinical testing of gene therapies targeting complement factor H and related inflammatory diseases.
Six diverse colorectal cancer cell lines enable research into tumour biology, differentiation, and integrin expression for drug development.
Transgenic mouse model mimics CMT1A pathology, enabling gene therapy testing for inherited neuropathies and autoimmune neurological disorders.
